(UVV) Universal - Overview

Sector: Consumer Defensive | Industry: Tobacco | Exchange: NYSE (USA) | Market Cap: 1.359m USD | Total Return: -15.6% in 12m

Leaf Tobacco, Plant Ingredients, Liquid Nicotine, Botanical Extracts
Total Rating 39
Safety 75
Buy Signal 0.01
Tobacco
Industry Rotation: -0.7
Market Cap: 1.36B
Avg Turnover: 8.69M
Risk 3d forecast
Volatility27.9%
VaR 5th Pctl4.47%
VaR vs Median-2.91%
Reward TTM
Sharpe Ratio-0.33
Rel. Str. IBD22.5
Rel. Str. Peer Group51.4
Character TTM
Beta0.143
Beta Downside0.213
Hurst Exponent0.381
Drawdowns 3y
Max DD29.70%
CAGR/Max DD0.19
CAGR/Mean DD0.40
EPS (Earnings per Share) EPS (Earnings per Share) of UVV over the last years for every Quarter: "2021-06": 0.3, "2021-09": 1.04, "2021-12": 1.4, "2022-03": 1.03, "2022-06": 0.27, "2022-09": 0.8763, "2022-12": 1.67, "2023-03": 0.97, "2023-06": -0.08, "2023-09": 1.12, "2023-12": 2.16, "2024-03": 1.6055, "2024-06": 0.0052, "2024-09": 1.032, "2024-12": 2.372, "2025-03": 2.37, "2025-06": 0.3381, "2025-09": 1.36, "2025-12": 1.32,
EPS CAGR: 23.04%
EPS Trend: 92.1%
Qual. Beats: 0
Revenue Revenue of UVV over the last years for every Quarter: 2021-06: 350.029, 2021-09: 453.955, 2021-12: 652.644, 2022-03: 646.973, 2022-06: 429.822, 2022-09: 650.984, 2022-12: 795.039, 2023-03: 693.979, 2023-06: 517.722, 2023-09: 638.484, 2023-12: 821.507, 2024-03: 770.86, 2024-06: 597.05, 2024-09: 710.762, 2024-12: 937.193, 2025-03: 702.279, 2025-06: 593.762, 2025-09: 754.177, 2025-12: 861.288,
Rev. CAGR: 5.71%
Rev. Trend: 91.0%
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: UVV Universal

Universal Corporation (UVV) is a global business-to-business agriproducts supplier operating through two primary segments: Tobacco Operations and Ingredients Operations. Founded in 1886, the company functions as a critical intermediary in the supply chain, procuring and processing raw materials for consumer-packaged goods manufacturers.

The Tobacco Operations segment manages the sourcing and logistics of various leaf varieties, including flue-cured and burley, while providing technical services like chemical testing and liquid nicotine production. In the tobacco industry, companies like Universal often operate on multi-year purchase commitments to mitigate agricultural supply volatility. The Ingredients Operations segment reflects a strategic diversification into plant-based extracts, fibers, and concentrates for the food and beverage sectors. This business model relies on large-scale processing infrastructure to convert raw agricultural commodities into high-value, standardized industrial inputs.

Investors may find it useful to evaluate the companys long-term dividend history and valuation metrics on ValueRay. This Richmond-based firm continues to leverage its global sourcing network to balance traditional tobacco processing with its expanding portfolio of natural food ingredients.

Headlines to Watch Out For
  • Global tobacco leaf supply shortages drive higher pricing and inventory valuations
  • Plant-based ingredients segment expansion reduces long-term reliance on cigarette leaf demand
  • High dividend yield remains primary driver for income-oriented institutional investors
  • Rising borrowing costs impact interest expense on seasonal leaf procurement debt
  • Global regulatory shifts toward smoke-free products alter traditional leaf volume requirements
Piotroski VR-10 (Strict) 3.0
Net Income: 85.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.46 > 1.0
NWC/Revenue: 49.18% < 20% (prev 46.30%; Δ 2.88% < -1%)
CFO/TA 0.03 > 3% & CFO 100.7m > Net Income 85.3m
Net Debt (1.06b) to EBITDA (283.5m): 3.75 < 3
Current Ratio: 2.91 > 1.5 & < 3
Outstanding Shares: last quarter (25.2m) vs 12m ago 1.91% < -2%
Gross Margin: 18.17% > 18% (prev 0.19%; Δ 1.80k% > 0.5%)
Asset Turnover: 96.12% > 50% (prev 99.19%; Δ -3.07% > 0%)
Interest Coverage Ratio: 2.88 > 6 (EBITDA TTM 283.5m / Interest Expense TTM 79.1m)
Altman Z'' 5.96
A: 0.47 (Total Current Assets 2.18b - Total Current Liabilities 751.4m) / Total Assets 3.02b
B: 0.40 (Retained Earnings 1.20b / Total Assets 3.02b)
C: 0.08 (EBIT TTM 228.1m / Avg Total Assets 3.03b)
D: 0.99 (Book Value of Equity 1.48b / Total Liabilities 1.49b)
Altman-Z'' = 5.96 = AAA
Beneish M -2.98
DSRI: 1.01 (Receivables 633.9m/650.0m, Revenue 2.91b/3.02b)
GMI: 1.06 (GM 18.17% / 19.35%)
AQI: 1.02 (AQ_t 0.14 / AQ_t-1 0.14)
SGI: 0.97 (Revenue 2.91b / 3.02b)
TATA: -0.01 (NI 85.3m - CFO 100.7m) / TA 3.02b)
Beneish M = -2.98 (Cap -4..+1) = A
What is the price of UVV shares?

As of June 01, 2026, the stock is trading at USD 51.87 with a total of 511,591 shares traded.
Over the past week, the price has changed by -5.05%, over one month by -3.19%, over three months by -1.44% and over the past year by -15.62%.

Is UVV a buy, sell or hold?

Universal has no consensus analysts rating.

What are the forecasts/targets for the UVV price?
Analysts Target Price 78 50.4%
Universal (UVV) - Fundamental Data Overview as of 01 June 2026
Market Cap USD = 1.36b (1.36b USD * 1.0 USD.USD)
P/E Trailing = 16.0826
P/E Forward = 12.3916
P/S = 0.4667
P/B = 0.9164
P/EG = 3.0977
Revenue TTM = 2.91b USD
EBIT TTM = 228.1m USD
EBITDA TTM = 283.5m USD
Long Term Debt = 616.6m USD (from longTermDebt, last quarter)
Short Term Debt = 473.5m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter) + Leases 34.8m
Net Debt = 1.06b USD (calculated: Debt 1.15b - CCE 85.2m)
Enterprise Value = 2.42b USD (1.36b + Debt 1.15b - CCE 85.2m)
Interest Coverage Ratio = 2.88 (Ebit TTM 228.1m / Interest Expense TTM 79.1m)
EV/FCF = 45.97x (Enterprise Value 2.42b / FCF TTM 52.7m)
FCF Yield = 2.18% (FCF TTM 52.7m / Enterprise Value 2.42b)
FCF Margin = 1.81% (FCF TTM 52.7m / Revenue TTM 2.91b)
Net Margin = 2.93% (Net Income TTM 85.3m / Revenue TTM 2.91b)
Gross Margin = 18.17% ((Revenue TTM 2.91b - Cost of Revenue TTM 2.38b) / Revenue TTM)
Gross Margin QoQ = 18.42% (prev 18.54%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.42b / Total Assets 3.02b)
Interest Expense / Debt = 6.89% (Interest Expense 79.1m / Debt 1.15b)
Taxrate = 37.83% (25.3m / 66.9m)
NOPAT = 141.8m (EBIT 228.1m * (1 - 37.83%))
Current Ratio = 2.91 (Total Current Assets 2.18b / Total Current Liabilities 751.4m)
Debt / Equity = 0.77 (Debt 1.15b / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 3.75 (Net Debt 1.06b / EBITDA 283.5m)
Debt / FCF = 20.18 (Net Debt 1.06b / FCF TTM 52.7m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.81% (Net Income 85.3m / Total Assets 3.02b)
RoE = 5.81% (Net Income TTM 85.3m / Total Stockholder Equity 1.47b)
RoCE = 10.94% (EBIT 228.1m / Capital Employed (Equity 1.47b + L.T.Debt 616.6m))
RoIC = 5.23% (NOPAT 141.8m / Invested Capital 2.71b)
WACC = 5.47% (E(1.36b)/V(2.51b) * Re(6.48%) + D(1.15b)/V(2.51b) * Rd(6.89%) * (1-Tc(0.38)))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.94 | Cagr: 0.31%
[DCF] Terminal Value 73.10% ; FCFF base≈58.5m ; Y1≈51.3m ; Y5≈41.4m
 [DCF] Fair Price = N/A (negative equity: EV 665.1m - Net Debt 1.06b = -398.2m; debt exceeds intrinsic value)
 EPS Correlation: 92.13 | EPS CAGR: 23.04% | SUE: N/A | # QB: 0
Revenue Correlation: 91.05 | Revenue CAGR: 5.71% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.34 | Chg30d=+13.33% | Revisions=+20% | Analysts=1